For example, oxaliplatin plus cyclophosphamide treatment of lung adenocarcinomas increased the ratio of CD8+ T cells vs. T-regs, increased the presence of tumor-specific CD8+ T cells, and resulted in enhanced expression of PD-1 and PD-L1 with subsequent improved responsiveness to ICB (40). This evidence concerns the gene CD8A and neoplasm.